Morning Overview on MSN

Intismeran autogene plus Keytruda dropped melanoma recurrence by close to 50% over five years in a Moderna-Merck-NYU trial unveiled at ASCO

Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside Keytruda saw their risk of disease ...

Will Jones

Jay Campbell, the author of Metabolic Awakening with GLP-1 Peptides, aims to reshape the narrative behind GLP-1 peptides, not ...